600566 济川药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)13.87922.86921.22620.36918.420
总资产报酬率 ROA (%)10.48517.04316.01315.18213.318
投入资产回报率 ROIC (%)12.35720.82219.53218.43316.493

边际利润分析
销售毛利率 (%)79.25881.52282.91183.27081.667
营业利润率 (%)36.51333.74726.93925.33023.828
息税前利润/营业总收入 (%)34.93631.48426.92424.39523.284
净利润/营业总收入 (%)32.85629.28224.14022.50520.717

收益指标分析
经营活动净收益/利润总额(%)86.19595.17794.72590.63797.034
价值变动净收益/利润总额(%)5.2472.9222.3488.2821.504
营业外收支净额/利润总额(%)5.0971.1813.3660.9030.980

偿债能力分析
流动比率 (X)3.7243.1003.2612.9003.343
速动比率 (X)3.5512.9933.1472.7663.201
资产负债率 (%)22.34826.31724.22224.73026.176
带息债务/全部投入资本 (%)9.8279.5954.9957.5957.288
股东权益/带息债务 (%)904.531929.4521,868.8771,190.5991,242.862
股东权益/负债合计 (%)346.868279.579312.426303.897282.026
利息保障倍数 (X)-9.874-11.805-28.242-20.923-29.858

营运能力分析
应收账款周转天数 (天)106.873103.62798.90395.507110.495
存货周转天数 (天)129.35688.94689.80892.21898.245